Eficácia de um produto à base de oxigênio ativo no tratamento não cirúrgico da Mucosite peri-implantar
Peri-implant mucositis is an inflammatory condition without loss of bone tissue, which occurs in the soft tissues around the implant. Non-surgical treatment combines basic periodontal therapy with or without the use of chemical agents. The objective of this study was to evaluate the efficacy of t...
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | Dissertação |
| Idioma: | pt_BR |
| Publicado em: |
Universidade Federal do Rio Grande do Norte
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/handle/123456789/31457 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| Resumo: | Peri-implant mucositis is an inflammatory condition without loss of bone tissue, which occurs
in the soft tissues around the implant. Non-surgical treatment combines basic periodontal
therapy with or without the use of chemical agents. The objective of this study was to evaluate
the efficacy of the active oxygen (Bluem®) as a chemical adjuvant in the non-surgical treatment
of peri-implant mucositis. Twenty implants in 9 patients were ramdomly treated, 9 in the test
group (Bluem®) and 11 in the control group (placebo), in individuals rehabilitated with dental
implants. Peri-implant clinical parameters of visible plaque index (VPI), gingival bleeding
index (GBI), probing depth (PD), bleeding on probing (BOP) and keratinized mucosa were
evaluated at baseline and one and six months. For the statistical analysis, Mann-Whitney,
Friedman, Wilcoxon and Fisher's Exact tests were used with a significance level of 5%. The
results showed that there was a statistical decrease for full mouth VPI (56.81% to 27.27%) and
full mouth GBI (32.95% to 28.41%) of the test group; full mouth VPI (42.86% to 15.18%) and
full mouth GBI (31.25% to 2.32%) of the control group; Implant VPI in the control group
(21.42% to 0%); probing depth for the test group (2.83mm to 2mm) and BOP for the control
group (33.33% to 16.67%). However, there were no significant differences between the two
groups. It can be concluded that Bluem can be used as a chemical adjuvant in the treatment of
peri-implant mucositis. |
|---|